212
Participants
Start Date
April 28, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Methotrexate
When accepted inclusion the patient will be included in SRQ, and thereafter randomised for Methotrexate per oral or subcutaneous administration
Region Sörmland, Eskilstuna
Region Dalarna, Falun
Region Gävleborg, Gävle
Region Norrbotten, Luleå
Reumatologsektionen Örebro universitetssjukhus, Öre
Region Jämtland Härjedalen, Östersund
Västra Götalandsregionen, Skövde
Akademiskt specialistcentrum, Stockholm
Danderyds sjukhus, Stockholm
Karolinska sjukhuset, Stockholm
Region Västernorrland, Sundsvall
Region Västerbotten, Umeå
Reumatologisk klinik, Västerås, Västerås
Region Gävleborg
OTHER
Umeå University
OTHER
Uppsala University
OTHER
County Council of Norrbotten, Sweden
OTHER_GOV
Vastra Gotaland Region
OTHER_GOV
Västernorrland County Council, Sweden
OTHER_GOV
Dalarna County Council, Sweden
OTHER
Karolinska University Hospital
OTHER
Region Jämtland Härjedalen
OTHER
Sormland County Council, Sweden
OTHER
Region Stockholm
OTHER_GOV
Region Västerbotten
OTHER_GOV